Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials

Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric dermatology 2019-05, Vol.36 (3), p.424-424
Format: Artikel
Sprache:eng
Schlagworte:
Erratum
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 424
container_issue 3
container_start_page 424
container_title Pediatric dermatology
container_volume 36
description
doi_str_mv 10.1111/pde.13877
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6885915</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2226417282</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3337-fcfac707a5dba7831787d99007f52d99d9e864b48d250298b6cb5aff2a502acb3</originalsourceid><addsrcrecordid>eNp1kstu1TAQhiMEoofCghdAltjQRVpfkthhgYTaUpAq0QWsLceXE1dOHOyEEl6KV2QO51ABEt54PP7m9-j3FMVzgk8JrLPJ2FPCBOcPig2paV2SiuOHxQZz1pQCV81R8STnW4yxaBryuDhiBLdtS_mm-HEVVh2nNaU4-mVAc8xrULNFfkSTNV7NyWs0JT-otCL1zYewC_p1sqn3JsXs82t0E_OM-qiRGlVYIYWiQ9Y5r5WGqtGgrJydV-T8aPy4zaiD9NYilyK8eRfR1Kts0dwna1GCgjj479YgHcc5xRAghEZUyE-LRw42--ywHxef311-On9fXn-8-nD-9rrUjDFeOu2U5pir2nSKC0a44KZtMeauphCY1oqm6iphaI1pK7pGd7Vyjio4Kt2x4-LNXndausEabaEPFeTBCBmVl3_fjL6X2_hVNkLULalB4NVBIMUvi82zHHzWFuwbbVyypJRR3LSs5oC-_Ae9jUsCJ3cUbSrCqaBAnewpDabnZN19MwTL3RhIGAP5awyAffFn9_fk738H4GwP3Plg1_8ryZuLy73kT4Wewl8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2226417282</pqid></control><display><type>article</type><title>Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials</title><source>Wiley Online Library Journals Frontfile Complete</source><identifier>ISSN: 0736-8046</identifier><identifier>EISSN: 1525-1470</identifier><identifier>DOI: 10.1111/pde.13877</identifier><identifier>PMID: 31099927</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Erratum</subject><ispartof>Pediatric dermatology, 2019-05, Vol.36 (3), p.424-424</ispartof><rights>2019 Wiley Periodicals, Inc.</rights><rights>Copyright © 2019 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3337-fcfac707a5dba7831787d99007f52d99d9e864b48d250298b6cb5aff2a502acb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fpde.13877$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fpde.13877$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31099927$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><title>Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials</title><title>Pediatric dermatology</title><addtitle>Pediatr Dermatol</addtitle><subject>Erratum</subject><issn>0736-8046</issn><issn>1525-1470</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kstu1TAQhiMEoofCghdAltjQRVpfkthhgYTaUpAq0QWsLceXE1dOHOyEEl6KV2QO51ABEt54PP7m9-j3FMVzgk8JrLPJ2FPCBOcPig2paV2SiuOHxQZz1pQCV81R8STnW4yxaBryuDhiBLdtS_mm-HEVVh2nNaU4-mVAc8xrULNFfkSTNV7NyWs0JT-otCL1zYewC_p1sqn3JsXs82t0E_OM-qiRGlVYIYWiQ9Y5r5WGqtGgrJydV-T8aPy4zaiD9NYilyK8eRfR1Kts0dwna1GCgjj479YgHcc5xRAghEZUyE-LRw42--ywHxef311-On9fXn-8-nD-9rrUjDFeOu2U5pir2nSKC0a44KZtMeauphCY1oqm6iphaI1pK7pGd7Vyjio4Kt2x4-LNXndausEabaEPFeTBCBmVl3_fjL6X2_hVNkLULalB4NVBIMUvi82zHHzWFuwbbVyypJRR3LSs5oC-_Ae9jUsCJ3cUbSrCqaBAnewpDabnZN19MwTL3RhIGAP5awyAffFn9_fk738H4GwP3Plg1_8ryZuLy73kT4Wewl8</recordid><startdate>201905</startdate><enddate>201905</enddate><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201905</creationdate><title>Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3337-fcfac707a5dba7831787d99007f52d99d9e864b48d250298b6cb5aff2a502acb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Erratum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pediatric dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials</atitle><jtitle>Pediatric dermatology</jtitle><addtitle>Pediatr Dermatol</addtitle><date>2019-05</date><risdate>2019</risdate><volume>36</volume><issue>3</issue><spage>424</spage><epage>424</epage><pages>424-424</pages><issn>0736-8046</issn><eissn>1525-1470</eissn><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31099927</pmid><doi>10.1111/pde.13877</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0736-8046
ispartof Pediatric dermatology, 2019-05, Vol.36 (3), p.424-424
issn 0736-8046
1525-1470
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6885915
source Wiley Online Library Journals Frontfile Complete
subjects Erratum
title Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T21%3A36%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glycopyrronium%20tosylate%20in%20pediatric%20primary%20axillary%20hyperhidrosis:%20Post%20hoc%20analysis%20of%20efficacy%20and%20safety%20findings%20by%20age%20from%20two%20phase%20three%20randomized%20controlled%20trials&rft.jtitle=Pediatric%20dermatology&rft.date=2019-05&rft.volume=36&rft.issue=3&rft.spage=424&rft.epage=424&rft.pages=424-424&rft.issn=0736-8046&rft.eissn=1525-1470&rft_id=info:doi/10.1111/pde.13877&rft_dat=%3Cproquest_pubme%3E2226417282%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2226417282&rft_id=info:pmid/31099927&rfr_iscdi=true